Sana Biotechnology (SANA) Assets (2020 - 2026)

Sana Biotechnology (SANA) has 7 years of Assets data on file, last reported at $373.6 million in Q1 2026.

• For the quarter ending Q1 2026, Assets fell 16.14% year-over-year to $373.6 million; the trailing twelve-month figure through Mar 2026 stood at $373.6 million (down 16.14% YoY), and the FY2025 full-year result was $416.9 million, down 16.79% from the prior year.
• Assets slipped to $373.6 million in Q1 2026, from $416.9 million in the prior quarter.
• In the past five years, Assets ranged from a high of $1.0 billion in Q1 2022 to a low of $361.6 million in Q2 2025.
• A 5-year average of $634.3 million and a median of $618.7 million in 2024 frame the typical range for Assets.
• Across the five-year window, Assets retreated 8.78% in 2024 and slumped 41.54% in 2025, its largest moves.
• Tracing SANA's Assets over 5 years: stood at $822.7 million in 2022, then plunged by 31.29% to $565.3 million in 2023, then slipped by 11.37% to $501.0 million in 2024, then declined by 16.79% to $416.9 million in 2025, then dropped by 10.39% to $373.6 million in 2026.
• Business Quant data shows SANA's Assets at $373.6 million in Q1 2026, $416.9 million in Q4 2025, and $435.4 million in Q3 2025.